当前位置： SCI文献检索 > Oncology Letters期刊下所有文献 > Prognostic evaluation of patients with resectable lung cancer using systemic inflammatory response parameters.

Prognostic evaluation of patients with resectable lung cancer using systemic inflammatory response parameters.

Abstract：

:Lung cancer is one of the leading causes of cancer-associated mortality. C-reactive protein (CRP), albumin (ALB), globulin (GLB), lactate dehydrogenase (LDH), neutrophil-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been identified as general parameters for systemic inflammatory response (SIR). Furthermore, these parameters are also associated with tumor development and metastasis. The present study aimed to investigate the predictive values of these SIR parameters in patients with resectable lung cancer. In total, 101 patients with resectable lung cancer were recruited in the present study. The patients were divided into two groups according to the median value of pre-treatment CRP, ALB, GLB, LDH, NLR or PLR values. The post-/pre-treatment ratios were defined as the ratio of pre-treatment blood parameter values and the corresponding values obtained following therapy. A ratio of ≤1.1 indicated that the values were not increased, while a ratio of >1.1 suggested that the values were increased following treatment. Patients with lower pre-treatment ALB levels had poorer overall survival (OS) rates, whereas GLB, LDH, CRP, NLR or PLR levels were not associated with outcomes. Whole course treatment (surgery combined with adjuvant chemotherapy) significantly increased the value of ALB, but decreased the value of NLR, whereas it had no effect on the values of LDH, CRP or PLR. Post-/pre-treatment LDH and PLR were associated with outcomes. Post-/pre-treatment ALB, GLB, CRP and NLR were not associated with outcomes. Multivariate analysis revealed that a low pre-treatment ALB level and increased post-/pre-treatment PLR were independent risk factors affecting OS. The receiver operating characteristic curve analysis demonstrated that an ALB value of 47.850 g/l was considered to be the optimal cut-off value for prognosis; the sensitivity was 28.8% and specificity was 95.9%. It was suggested that the pre-treatment ALB and post-/pre-treatment PLR may be potential prognostic factors in resectable lung cancer.

journal_name

Oncol Lett

journal_title

Oncology letters

authors

Zhu J,Lian L,Qin H,Wang WJ,Ren R,Xu MD,Chen K,Duan W,Gong FR,Tao M,Zhi Q,Wu MY,Li W

doi

10.3892/ol.2018.9858

subject

Has Abstract

pub_date

2019-02-01 00:00:00

pages

2244-2256

issue

eissn

1792-1074

issn

1792-1082

pii

OL-0-0-9858

journal_volume

pub_type

杂志文章

在线工具

Prognostic evaluation of patients with resectable lung cancer using systemic inflammatory response parameters.